Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review
Thank you for Subscribing to Healthcare Business Review Weekly Brief
Om1 Introduces New Mental Health And Neuroscience Real-World Data Network
Artificial intelligence software development has enormous potential in behavioral and mental health care.
By
Healthcare Business Review | Thursday, June 16, 2022
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Fremont, CA: Artificial intelligence software development has enormous potential in behavioral and mental health care. ArtificialIntelligence.health is a company that develops AI software with the goal of promoting the use of AI in mental health care.
OM1, a leading technology-enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic diseases, has launched its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur Dr. Carl D. Marci. The division includes new information on psychiatric disorders and diseases of the central nervous system (CNS) with an initial focus on major depression, bipolar disorder, schizophrenia, and multiple sclerosis (MS), with other condition areas to follow.
In the US, there is an unmet and growing medical need for mental health and CNS disorders. The pandemic has exacerbated mental health disorders, in particular, resulting in a national crisis.